Literature DB >> 21664051

Eugenol reverses mechanical allodynia after peripheral nerve injury by inhibiting hyperpolarization-activated cyclic nucleotide-gated (HCN) channels.

Kyu-Yong Yeon1, Gehoon Chung, Yong Ho Kim, Jae Hong Hwang, Alexander J Davies, Min-Kyoung Park, Dong Kuk Ahn, Joong Soo Kim, Sung Jun Jung, Seog Bae Oh.   

Abstract

Mechanical allodynia is a common symptom found in neuropathic patients. Hyperpolarization-activated cyclic nucleotide-gated channels and their current, I(h), have been suggested to play an important role in neuropathic pain, especially in mechanical allodynia and spontaneous pain, by involvement in spontaneous ectopic discharges after peripheral nerve injury. Thus, I(h) blockers may hold therapeutic potential for the intervention of mechanical allodynia under diverse neuropathic conditions. Here we show that eugenol blocks I(h) and abolishes mechanical allodynia in the trigeminal system. Eugenol produced robust inhibition of I(h) with IC(50) of 157 μM in trigeminal ganglion (TG) neurons, which is lower than the dose of eugenol that inhibits voltage-gated Na channels. Eugenol-induced I(h) inhibition was not mediated by G(i/o)-protein activation, but was gradually diminished by an increase in intracellular cAMP concentration. Eugenol also inhibited I(h) from injured TG neurons which were identified by retrograde labeling with DiI and reversed mechanical allodynia in the orofacial area after chronic constriction injury of infraorbital nerve. We propose that eugenol could be potentially useful for reversing mechanical allodynia in neuropathic pain patients.
Copyright © 2011 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21664051     DOI: 10.1016/j.pain.2011.05.018

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  14 in total

Review 1.  Neuroplasticity of ascending and descending pathways after somatosensory system injury: reviewing knowledge to identify neuropathic pain therapeutic targets.

Authors:  P Boadas-Vaello; S Castany; J Homs; B Álvarez-Pérez; M Deulofeu; E Verdú
Journal:  Spinal Cord       Date:  2016-01-12       Impact factor: 2.772

2.  HCN1 channels as targets for anesthetic and nonanesthetic propofol analogs in the amelioration of mechanical and thermal hyperalgesia in a mouse model of neuropathic pain.

Authors:  Gareth R Tibbs; Thomas J Rowley; R Lea Sanford; Karl F Herold; Alex Proekt; Hugh C Hemmings; Olaf S Andersen; Peter A Goldstein; Pamela D Flood
Journal:  J Pharmacol Exp Ther       Date:  2013-04-02       Impact factor: 4.030

3.  Central neural alterations predominate in an insect model of nociceptive sensitization.

Authors:  Dennis R Tabuena; Allan Solis; Ken Geraldi; Christopher A Moffatt; Megumi Fuse
Journal:  J Comp Neurol       Date:  2016-10-24       Impact factor: 3.215

Review 4.  Recent development in antihyperalgesic effect of phytochemicals: anti-inflammatory and neuro-modulatory actions.

Authors:  Ajeet Kumar Singh; Sanjay Kumar; Manjula Vinayak
Journal:  Inflamm Res       Date:  2018-05-16       Impact factor: 4.575

Review 5.  Recent advances in basic research on the trigeminal ganglion.

Authors:  Tetsuya Goto; Seog Bae Oh; Mamoru Takeda; Masamichi Shinoda; Tadasu Sato; Kaori K Gunjikake; Koichi Iwata
Journal:  J Physiol Sci       Date:  2016-03-29       Impact factor: 2.781

6.  Fractionation of a herbal antidiarrheal medicine reveals eugenol as an inhibitor of Ca2+-Activated Cl- channel TMEM16A.

Authors:  Zhen Yao; Wan Namkung; Eun A Ko; Jinhong Park; Lukmanee Tradtrantip; A S Verkman
Journal:  PLoS One       Date:  2012-05-30       Impact factor: 3.240

7.  The effect of eugenol on the cariogenic properties of Streptococcus mutans and dental caries development in rats.

Authors:  Jing-Shu Xu; Yao Li; Xue Cao; Yun Cui
Journal:  Exp Ther Med       Date:  2013-04-17       Impact factor: 2.447

8.  Eugenol inhibits the GABAA current in trigeminal ganglion neurons.

Authors:  Sang Hoon Lee; Jee Youn Moon; Sung Jun Jung; Jin Gu Kang; Seung Pyo Choi; Jun Ho Jang
Journal:  PLoS One       Date:  2015-01-30       Impact factor: 3.240

9.  A Novel Carbamoyloxy Arylalkanoyl Arylpiperazine Compound (SKL-NP) Inhibits Hyperpolarization-Activated Cyclic Nucleotide-Gated (HCN) Channel Currents in Rat Dorsal Root Ganglion Neurons.

Authors:  Gehoon Chung; Tae-Hyung Kim; Hyewon Shin; Eunhee Chae; Hanju Yi; Hongsik Moon; Hyun Jin Kim; Joong Soo Kim; Sung Jun Jung; Seog Bae Oh
Journal:  Korean J Physiol Pharmacol       Date:  2012-08-10       Impact factor: 2.016

10.  Inhibition of G protein-coupled P2Y2 receptor induced analgesia in a rat model of trigeminal neuropathic pain.

Authors:  Na Li; Zhan-ying Lu; Li-hua Yu; Geoffrey Burnstock; Xiao-ming Deng; Bei Ma
Journal:  Mol Pain       Date:  2014-03-18       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.